Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FXAEE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $89,498
Award facts
- Contract value 100% obligated
- $89,497.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $89,497.61 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on September 17, 2025, with completion scheduled for September 18, 2025. This is a firm fixed-price, non-competitive delivery order issued under a competitively awarded contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. Dupixent is a biologic medication indicated for various inflammatory conditions, and this procurement supports the federal government's medical supply chain requirements for military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. As the child delivery order under this prime contract, the award reflects AmerisourceBergen Drug Corp's established capability to meet federal pharmaceutical procurement requirements through open competition and its critical role in sustaining the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FXAEE?
SPE2DB25FXAEE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FXAEE worth?
The government has obligated $89,498 on SPE2DB25FXAEE.
Is contract SPE2DB25FXAEE an order under another contract?
Yes. SPE2DB25FXAEE is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FXAEE competed?
The extent of competition for SPE2DB25FXAEE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award